Literature DB >> 1937687

Twenty-year follow-up of hemodynamics in essential hypertension during rest and exercise.

P Lund-Johansen1.   

Abstract

Central hemodynamics were studied invasively (blood pressure intra-arterially and cardiac output by dye-dilution method) at rest and during exercise in men with essential hypertension and in age-matched normotensive controls. At the start of the study, resting cardiac index, heart rate, oxygen consumption, and mean arterial pressure were approximately 15% higher in those hypertensive patients aged 17-29 years than in normotensive subjects, whereas total peripheral resistance index was similar in both groups. During exercise, the stroke index was reduced and total peripheral resistance index was increased in the hypertensive group. After 10 and then 20 years, central hemodynamics were restudied in the hypertensive patients. The initially high cardiac index/normal total peripheral resistance index pattern changed to a low cardiac index/high resistance pattern at 10- and 20-year follow-up. In 25 patients initially aged 40-49 years, treatment with diuretics, beta-blockers, or a combination of the two normalized diastolic pressure. In spite of adequate blood pressure control, a marked increase in total peripheral resistance and fall in cardiac index and stroke index were also seen in this age group treated over 20 years. The study has shown a progressively abnormal hemodynamic pattern over two decades in patients of different ages with essential hypertension.

Entities:  

Mesh:

Year:  1991        PMID: 1937687     DOI: 10.1161/01.hyp.18.5_suppl.iii54

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Matching the right drug to the right patient in essential hypertension.

Authors:  M J Brown
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

2.  Exercise Pressor Reflex Contributes to the Cardiovascular Abnormalities Characterizing: Hypertensive Humans During Exercise.

Authors:  Simranjit K Sidhu; Joshua C Weavil; Matthew J Rossman; Jacob E Jessop; Amber D Bledsoe; Michael J Buys; Mark S Supiano; Russell S Richardson; Markus Amann
Journal:  Hypertension       Date:  2019-10-14       Impact factor: 10.190

3.  Differential effects of nebivolol versus metoprolol on functional sympatholysis in hypertensive humans.

Authors:  Angela Price; Prafull Raheja; Zhongyun Wang; Debbie Arbique; Beverley Adams-Huet; Jere H Mitchell; Ronald G Victor; Gail D Thomas; Wanpen Vongpatanasin
Journal:  Hypertension       Date:  2013-04-01       Impact factor: 10.190

Review 4.  Functional sympatholysis in hypertension.

Authors:  Gail D Thomas
Journal:  Auton Neurosci       Date:  2014-10-23       Impact factor: 3.145

5.  Functional sympatholysis is impaired in hypertensive humans.

Authors:  Wanpen Vongpatanasin; Zhongyun Wang; Debbie Arbique; Gary Arbique; Beverley Adams-Huet; Jere H Mitchell; Ronald G Victor; Gail D Thomas
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

6.  Dynamic exercise training prevents exercise pressor reflex overactivity in spontaneously hypertensive rats.

Authors:  Masaki Mizuno; Gary A Iwamoto; Wanpen Vongpatanasin; Jere H Mitchell; Scott A Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-10       Impact factor: 4.733

7.  Exercise training improves functional sympatholysis in spontaneously hypertensive rats through a nitric oxide-dependent mechanism.

Authors:  Masaki Mizuno; Gary A Iwamoto; Wanpen Vongpatanasin; Jere H Mitchell; Scott A Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-09       Impact factor: 4.733

8.  Hemodynamic determinants of chronic hypotension and their modification through vasopressor application.

Authors:  Stefan Duschek; Heike Heiss; Boriana Buechner; Natalie Werner; Rainer Schandry; Gustavo A Reyes del Paso
Journal:  J Physiol Sci       Date:  2008-12-26       Impact factor: 2.781

9.  Physical activity and hemodynamic reactivity in chronic kidney disease.

Authors:  Rajiv Agarwal; Robert P Light
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

Review 10.  Treatment of hypertension in the elderly--what have we learned from the recent trials?

Authors:  P Lund-Johansen
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.